Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Short-term Investments: 2011-2017

Historic Short-term Investments for EyePoint Pharmaceuticals (EYPT) over the last 6 years, with Mar 2017 value amounting to $2.5 million.

  • EyePoint Pharmaceuticals' Short-term Investments fell 70.27% to $2.5 million in Q1 2017 from the same period last year, while for Mar 2017 it was $2.5 million, marking a year-over-year decrease of 70.27%. This contributed to the annual value of $13.7 million for FY2016, which is 45.30% up from last year.
  • EyePoint Pharmaceuticals' Short-term Investments amounted to $2.5 million in Q1 2017, which was down 57.26% from $5.8 million recorded in Q4 2016.
  • In the past 5 years, EyePoint Pharmaceuticals' Short-term Investments ranged from a high of $13.7 million in Q2 2016 and a low of $502,000 during Q4 2013.
  • Its 3-year average for Short-term Investments is $8.5 million, with a median of $8.7 million in 2015.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Short-term Investments crashed by 92.05% in 2013 and then surged by 1,082.27% in 2014.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Short-term Investments stood at $502,000 in 2013, then soared by 1,082.27% to $5.9 million in 2014, then spiked by 66.49% to $9.9 million in 2015, then plummeted by 40.83% to $5.8 million in 2016, then plummeted by 70.27% to $2.5 million in 2017.
  • Its last three reported values are $2.5 million in Q1 2017, $5.8 million for Q4 2016, and $8.2 million during Q3 2016.